- Home
- LITB vs CRIS Comparison
LITB vs CRIS Comparison
Compare LITB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- CRIS
- Stock Information
- Founded
- LITB 2007
- CRIS 2000
- Country
- LITB Singapore
- CRIS United States
- Employees
- LITB N/A
- CRIS N/A
- Industry
- LITB Catalog/Specialty Distribution
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- CRIS Health Care
- Exchange
- LITB Nasdaq
- CRIS Nasdaq
- Market Cap
- LITB 20.5M
- CRIS 21.3M
- IPO Year
- LITB N/A
- CRIS 2000
- Fundamental
- Price
- LITB $1.16
- CRIS $1.75
- Analyst Decision
- LITB
- CRIS Strong Buy
- Analyst Count
- LITB 0
- CRIS 2
- Target Price
- LITB N/A
- CRIS $16.50
- AVG Volume (30 Days)
- LITB 10.6K
- CRIS 128.9K
- Earning Date
- LITB 08-01-2025
- CRIS 07-31-2025
- Dividend Yield
- LITB N/A
- CRIS N/A
- EPS Growth
- LITB N/A
- CRIS N/A
- EPS
- LITB 0.08
- CRIS N/A
- Revenue
- LITB $231,136,000.00
- CRIS $11,202,000.00
- Revenue This Year
- LITB N/A
- CRIS N/A
- Revenue Next Year
- LITB N/A
- CRIS $10.67
- P/E Ratio
- LITB $15.16
- CRIS N/A
- Revenue Growth
- LITB N/A
- CRIS 14.17
- 52 Week Low
- LITB $0.91
- CRIS $1.02
- 52 Week High
- LITB $5.70
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- LITB 45.65
- CRIS 34.36
- Support Level
- LITB $1.11
- CRIS $2.11
- Resistance Level
- LITB $1.25
- CRIS $2.48
- Average True Range (ATR)
- LITB 0.09
- CRIS 0.21
- MACD
- LITB 0.01
- CRIS -0.06
- Stochastic Oscillator
- LITB 34.00
- CRIS 17.36
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.